Riskpilot← Back to searchSign inGet full accessNYT SYN AARS ApS
APSActiveCVR 34902739Anlægsvej 6Retail sale of medical and orthopaedic goods · NACE 4774Est. 20133 employees
Revenue 2024
DKK 2,4M
-3% vs 2023
EBITDA margin
33.3%
+1255% vs 2023
Equity ratio
60.2%
Financial strength
Net profit 2024
DKK 605K
+1195% vs 2023
| Revenue | DKK 2,4M | -3% |
| EBITDA | DKK 807K | +1255% |
| Net profit | DKK 605K | +1195% |
| Total assets | DKK 2,9M | +50% |
| Equity | DKK 1,7M | +54% |
| Employees | 3 | — |
Legal name
NYT SYN AARS ApS
CVR number
34902739
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
10. januar 2013
Share capital
DKK 200.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskaber - at udøve optikervirksomhed samt anden virksomhed, der efter det centrale ledelsesorgans skøn er forbundet hermed.
Address
Anlægsvej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 698 | 1.007 | 1.081 | 1.553 | 1.049 | 2.197 | 1.829 | 2.150 | 2.412 | 2.627 | 2.503 | 2.427 |
| Staff expenses | -838 | -1.065 | -1.064 | -1.081 | -1.235 | -1.231 | -1.468 | -1.400 | -1.503 | -2.163 | -2.572 | -1.620 |
| EBITDA | -141 | -58 | 18 | 471 | -186 | 966 | 362 | 750 | 909 | 456 | -70 | 807 |
| Depreciation & amort. | -121 | -142 | -136 | -136 | -155 | -70 | -43 | -50 | -52 | -29 | -17 | -17 |
| EBIT | -262 | -200 | -119 | 335 | -342 | 895 | 319 | 700 | 857 | 427 | -87 | 790 |
| Net financials | -36 | -55 | -37 | -20 | -25 | -10 | -3 | 11 | 25 | 36 | 17 | -14 |
| Profit before tax | -298 | -255 | -155 | 315 | -367 | 885 | 316 | 710 | 882 | 463 | -70 | 776 |
| Tax | -64 | -55 | -34 | 72 | -79 | 197 | 70 | 159 | 197 | 103 | -14 | 171 |
| Net profit | -234 | -200 | -121 | 243 | -288 | 689 | 245 | 552 | 686 | 360 | -55 | 605 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 950 | 1.078 | 947 | 901 | 1.169 | 1.516 | 1.832 | 2.634 | 2.948 | 1.790 | 1.919 | 2.872 |
| Equity | -34 | -234 | 193 | 436 | 148 | 837 | 1.082 | 1.634 | 2.320 | 1.180 | 1.125 | 1.729 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 985 | 1.312 | 754 | 465 | 1.021 | 679 | 691 | 1.000 | 629 | 610 | 795 | 1.142 |
| Total debt | 985 | 1.312 | 754 | 465 | 1.021 | 679 | 749 | 1.000 | 629 | 610 | 795 | 1.142 |
EBITDA margin
33.3%
This company
15.8%
Market median
+111% vs market
20132024
Equity ratio
60.2%
This company
38.2%
Market median
+58% vs market
20132024
Return on equity
35.0%
This company
18.4%
Market median
+90% vs market
20132024
Net profit margin
24.9%
This company
8.1%
Market median
+207% vs market
20132024
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20132024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-10 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KS Management | Management | 2013 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KK HOLDING, AARS ApS | Company | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KK HOLDING, AARS ApS
NYT SYN AARS ApS Board members of NYT SYN AARS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kent Sørensen | Management | 0 companies |